Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review-Reference-Cited by-同舟云学术

Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review

Published:2020-05-16 Issue:11 Volume:39 Page:3287-3294
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Hu Anna M.^ORCID,Brown Jamie N.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-020-05079-3.pdf

Reference40 articles.

1. Krishnan E (2012) Reduced glomerular function and prevalence of gout: NHANES 2009-10. PLoS One 7(11):e50046. https://doi.org/10.1371/journal.pone.0050046

2. Lipkowitz MS (2012) Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep 14(2):179–188. https://doi.org/10.1007/s11926-012-0240-z

3. Nakagawa T, Mazzali M, Kang DH, Sanchez-Lozada LG, Herrera-Acosta J, Johnson RJ (2006) Uric acid--a uremic toxin? Blood Purif 24(1):67–70. https://doi.org/10.1159/000089440

4. Li L, Yang C, Zhao YL, Zeng XX, Liu F, Fu P (2014) Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies. BMC Nephrol 15:12. https://doi.org/10.1186/1471-2369-15-122

5. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS (2008) Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19(6):1204–1211. https://doi.org/10.1681/ASN.2007101075

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of flavonoids in the treatment of gouty arthritis (Review);Molecular Medicine Reports;2024-05-28

2. Comparison of the therapeutic effects of febuxostat combined with a low‐purine diet and allopurinol combined with a low‐purine diet on the improvement of gout patients;International Journal of Rheumatic Diseases;2024-05

3. Timing of Initiation of Xanthine Oxidase Inhibitors Based on Serum Uric Acid Level Does Not Predict Renoprognosis in Patients with Preserved Kidney Function;Metabolic Syndrome and Related Disorders;2024-04-01

4. Chronic miliary gout complicated by chronic renal failure: a case report;Scandinavian Journal of Rheumatology;2024-02-26

5. Untargeted Metabolomics Analysis of Chlorogenic Acid Using Rat Models with 5/6 Nephrectomy and Hyperuricemia;J BIOL REG HOMEOS AG;2024